Your browser doesn't support javascript.
loading
Influence of ziprasidone combined with amend electric shock on efficacy and metabolism of patients with first-episode schizophrenia / 药物评价研究
Drug Evaluation Research ; (6): 241-244, 2017.
Article em Zh | WPRIM | ID: wpr-515127
Biblioteca responsável: WPRO
ABSTRACT
Objective To investigate the influence of ziprasidone combined with amend electric shock on the efficacy and metabolism of patients with first-episode schizophrenia.Methods According to random number table,86 cases with first-episode schizophrenia from July 2013 to July 2016 in the Second Affiliated Hospital of Xinxiang Medical University were chosen and divided into observation group and control group.The patients in observation group were given ziprasidone combined with first-episode schizophrenia,the patients in control group were taken with olanzapine combined with first-episode schizophrenia.The PANSS total score,CGI score,total efficacy,adverse reaction,body mass index,glycometabolism,and lipid metabolism of two groups were observed and compared.Results The PANSS score,CGI score of two groups were all obvious decreased,which had no significant difference,the total efficacy of two groups had no significant difference;The TESS scores were all decreased,and the TESS score of observation group was obviously lower than that of control group (P < 0.05).Compared with before treatment,the BMI,fasting blood sugar,triglyceride,total cholesterol,high/low density lipoprotein and fasting insulin level of observation group after treatment had no obvious significant difference,while the BMI,fasting blood sugar,triglyceride,total cholesterol,low density lipoprotein,and fasting insulin levels of control group had obvious significant difference,and the BMI,fasting blood sugar,triglyceride,total cholesterol,and fasting insulin of observation group were obviously lower than control group (P < 0.05).Conclusion Olanzapine and ziprasidone combined with amend electric shock have obvious efficacy on patients with first-episode schizophrenia,while the ziprasidone had lower adverse reaction and metabolic side effects,which is worth of clinical promotion and application.
Palavras-chave
Texto completo: 1 Índice: WPRIM Tipo de estudo: Prognostic_studies Idioma: Zh Revista: Drug Evaluation Research Ano de publicação: 2017 Tipo de documento: Article
Texto completo: 1 Índice: WPRIM Tipo de estudo: Prognostic_studies Idioma: Zh Revista: Drug Evaluation Research Ano de publicação: 2017 Tipo de documento: Article